Portugal, April 1 -- Portugal based Pharmis Biofarmaceutica, Lda. has secured contract from Unidade Local De Saude Da Leziria, E. P. E. for Invitation To Present A Proposal By Direct Award For The Acquisition Of O4 - Octreotide [0.1 Mg/1Ml; F/Amp]. The value of the contract is worth 155155 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....